Omalizumab Therapy for Allergic Bronchopulmonary Aspergillosis in Children with Cystic Fibrosis: A Synthesis of Published Evidence

被引：52

作者：

Tanou, Kalliopi ^{[1
,2
]}

Zintzaras, Elias ^{[3
,4
]}

Kaditis, Athanasios G. ^{[1
,2
]}

机构：

[1] Univ Athens, Sch Med, Dept Pediat 1, Pediat Pulmonol Unit, GR-11527 Athens, Greece

[2] Aghia Sophia Childrens Hosp, Athens, Greece

[3] Tufts Univ, Sch Med, Tufts Med Ctr, Ctr Clin Evidence Synth,Inst Clin Res & Hlth Poli, Boston, MA 02111 USA

[4] Univ Thessaly, Sch Med, Dept Biomath, Larisa, Greece

来源：

PEDIATRIC PULMONOLOGY | 2014年 / 49卷 / 05期

关键词：

ABPA; A; fumigatus; anti-IgE; ANTI-IGE ANTIBODY; ABPA; CF;

D O I：

10.1002/ppul.22937

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

Allergic bronchopulmonary aspergillosis (ABPA) complicating cystic fibrosis (CF) is treated with corticosteroids. Since elevated IgE is a cardinal abnormality, anti-IgE has been used sporadically as adjuvant treatment. In eight case reports, 13 children with CF and ABPA received anti-IgE resulting in improved FEV1, fewer respiratory symptoms and decreased corticosteroid use. Pediatr Pulmonol. 2014; 49:503-507. (c) 2013 Wiley Periodicals, Inc.

引用

页码：503 / 507

页数：5

共 13 条

[1] Steroid dependency despite omalizumab treatment of ABPA in cystic fibrosis [J].

Brinkmann, F. ;

Schwerk, N. ;

Hansen, G. ;

Ballmann, M. .

ALLERGY, 2010, 65 (01) :134-135

[2] Effects of treatment with anti-immunoglobulin E antibody omalizumab on airway inflammation in allergic asthma [J].

Djukanovic, R ;

Wilson, SJ ;

Kraft, M ;

Jarjour, NN ;

Steel, M ;

Chung, KF ;

Bao, WB ;

Fowler-Taylor, A ;

Matthews, J ;

Busse, WW ;

Holgate, ST ;

Fahy, JV .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2004, 170 (06) :583-593

[3]

Elmallah Mai K, 2012, J Pediatr Pharmacol Ther, V17, P88, DOI 10.5863/1551-6776-17.1.88

[4] Treatment of Allergic Bronchopulmonary Aspergillosis (ABPA) in CF With Anti-IgE Antibody (Omalizumab) [J].

Kanu, Adaobi ;

Patel, Kalpana .

PEDIATRIC PULMONOLOGY, 2008, 43 (12) :1249-1251

[5]

Lebecque P, 2009, BMJ CASE REP, V2009

[6] Omalizumab for Treatment of ABPA Exacerbations in CF Patients [J].

Lebecque, Patrick ;

Leonard, Anissa ;

Pilette, Charles .

PEDIATRIC PULMONOLOGY, 2009, 44 (05) :516-516

[7] Omalizumab rapidly decreases nasal allergic response and FcεRI on basophils [J].

Lin, H ;

Boesel, KM ;

Prussin, C ;

Foster, B ;

Romero, FA ;

Townley, R ;

Casale, TB .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2004, 113 (02) :297-302

[8] Resolution of Corticosteroid-Induced Diabetes in Allergic Bronchopulmonary Aspergillosis with Omalizumab Therapy: A Novel Approach [J].

Randhawa, Inderpal ;

Chin, Terry ;

Nussbaum, Eliezer .

JOURNAL OF ASTHMA, 2009, 46 (05) :445-447

[9]

Soresi S, 2006, ALLERGY ASTHMA PROC, V27, pS15

[10] Allergic bronchopulmonary aspergillosis in cystic fibrosis - State of the art: Cystic Fibrosis Foundation Consensus Conference [J].

Stevens, DA ;

Moss, RB ;

Kurup, VP ;

Knutsen, AP ;

Greenberger, P ;

Judson, MA ;

Denning, DW ;

Crameri, R ;

Brody, AS ;

Light, M ;

Skov, M ;

Maish, W ;

Mastella, G .

CLINICAL INFECTIOUS DISEASES, 2003, 37 :S225-S264

← 1 2 →